[go: up one dir, main page]

MXPA97007996A - Preparado para el transporte de sustancias activas a traves de barreras. - Google Patents

Preparado para el transporte de sustancias activas a traves de barreras.

Info

Publication number
MXPA97007996A
MXPA97007996A MXPA97007996A MX9707996A MXPA97007996A MX PA97007996 A MXPA97007996 A MX PA97007996A MX PA97007996 A MXPA97007996 A MX PA97007996A MX 9707996 A MX9707996 A MX 9707996A MX PA97007996 A MXPA97007996 A MX PA97007996A
Authority
MX
Mexico
Prior art keywords
preparation
active substance
transport
barriers
solubilization
Prior art date
Application number
MXPA97007996A
Other languages
English (en)
Inventor
Cevc Gregor
Original Assignee
Idea Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27179110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA97007996(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idea Ag filed Critical Idea Ag
Publication of MXPA97007996A publication Critical patent/MXPA97007996A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Preparado para la aplicacion de sustancias activas en forma de gotas de liquido pequenisimas, particularmente con una envoltura tipo membrana de una o pocas capas de moleculas anfifilas, o bien, pequenas gotas de liquido provistas de una sustancia acarreadora, en particular para el transporte de la sustancia activa en y a traves de barreras naturales y constricciones, como pieles y similares. El preparado no presenta ningun punto de solubilizacion y la composicion del preparado, a una capacidad maxima de permeacion, esta lejos del punto de solubilizacion. El preparado presenta un contenido de al menos dos componentes, los cuales, en su solubilidad en el medio de suspension de los preparados, usualmente agua, se diferencian por al menos el factor 10.
MXPA97007996A 1994-12-30 1996-10-17 Preparado para el transporte de sustancias activas a traves de barreras. MXPA97007996A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4447287A DE4447287C1 (de) 1994-12-30 1994-12-30 Präparat zum Wirkstofftransport durch Barrieren
CNB961804734A CN1151777C (zh) 1994-12-30 1996-10-17 转运活性成分通过屏障的制剂
PCT/EP1996/004526 WO1998017255A1 (de) 1994-12-30 1996-10-17 Präparat zum wirkstofftransport durch barrieren

Publications (1)

Publication Number Publication Date
MXPA97007996A true MXPA97007996A (es) 2004-03-15

Family

ID=27179110

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA97007996A MXPA97007996A (es) 1994-12-30 1996-10-17 Preparado para el transporte de sustancias activas a traves de barreras.

Country Status (13)

Country Link
EP (1) EP0935457B1 (es)
JP (1) JP2001502676A (es)
KR (1) KR100446832B1 (es)
CN (1) CN1151777C (es)
AT (1) ATE257373T1 (es)
AU (1) AU724218B2 (es)
BR (1) BR9612750A (es)
CA (1) CA2268670A1 (es)
DE (2) DE4447287C1 (es)
ES (1) ES2211984T3 (es)
HU (1) HUP9903363A3 (es)
MX (1) MXPA97007996A (es)
WO (1) WO1998017255A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
EP1039880A1 (en) * 1998-10-23 2000-10-04 Idea Innovative Dermale Applikationen GmbH Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
JP2002528394A (ja) * 1998-10-28 2002-09-03 インビトロジェン コーポレイション 植物細胞の成長を調節する化合物を含有する組成物、およびその使用方法
HRP20010309B1 (en) 1998-12-23 2005-06-30 Idea Ag Improved formulation for topical non-invasive application in vivo
ATE216223T1 (de) 1999-01-27 2002-05-15 Idea Ag Transnasaler transport bzw. impfung mit hochadaptierbaren trägern
DE69901377T2 (de) 1999-01-27 2003-01-02 Idea Ag Nichtinvasive Impfung durch die Haut
WO2001001962A1 (en) 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
AU2136501A (en) * 1999-12-10 2001-06-18 Celator Technologies Inc. Lipid carrier compositions with protected surface reactive functions
DK1551370T3 (da) * 2002-10-11 2008-03-03 Idea Ag Aggregat med foröget deformerbarhed, som omfatter mindst tre amfipater, til forbedret transport gennem semipermeable barrierer og til ikke-invasiv lægemiddeltilförsel in vivo, især gennem huden
US7473432B2 (en) 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
LT1585548T (lt) * 2002-12-09 2018-09-25 Abraxis Bioscience, Llc Farmakologinių agentų kompozicijos ir įvedimo būdai
DE102008034098A1 (de) 2008-07-21 2010-02-04 Lts Lohmann Therapie-Systeme Ag Zubereitung und lontophoretische Vorrichtung für die transdermale Anwendung von Wirkstoffen
CN102639113A (zh) 2009-06-03 2012-08-15 J·C·梅奥 用于治疗深部组织疼痛的制剂
KR20120129864A (ko) 2009-08-21 2012-11-28 타겟티드 딜리버리 테크놀러지스 리미티드 소포성 제형
WO2013057208A1 (en) 2011-10-18 2013-04-25 Targeted Delivery Technologies Limited Compositions and methods for reducing the proliferation and viability of microbial agents
CN102579350B (zh) * 2012-03-02 2013-04-24 海南灵康制药有限公司 右旋布洛芬脂质体固体制剂
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
ES2895910T3 (es) 2015-06-30 2022-02-23 Sequessome Tech Holdings Limited Composiciones multifásicas
CH713023A2 (de) * 2016-10-11 2018-04-13 Kuhs Bernd Verfahren zur Herstellung von dermatologischen und kosmetischen Präparaten mit ausgeprägten lamellaren Strukturen unter Verwendung von Phosphatidylcholin und biologischen Zellmaterialien, welche durch die Einwirkung von Ultraschallwellen aufgeschlossen werden und gleichzeitig zwischen den lamellaren Strukturen eingelagert werden.
WO2019023247A1 (en) 2017-07-25 2019-01-31 Immutics, Inc. TREATMENT OF CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND ITS LIGAND
EP3918323A4 (en) 2019-01-30 2022-12-28 TrueBinding, Inc. ANTI-GAL3 ANTIBODIES AND USES THEREOF
CN110101591B (zh) * 2019-05-23 2022-01-18 广州科斯曼生物科技有限公司 一种长效保湿组合物及其制备方法和应用
WO2021242776A2 (en) 2020-05-26 2021-12-02 Truebinding, Inc. Methods of treating inflammatory diseases by blocking galectin-3

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921706A (en) * 1984-11-20 1990-05-01 Massachusetts Institute Of Technology Unilamellar lipid vesicles and method for their formation
DE3542773A1 (de) * 1985-12-04 1987-06-11 Roehm Pharma Gmbh Hautwirksame pharmaka mit liposomen als wirkstofftraeger
US5064655A (en) * 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method
FR2649155B1 (fr) * 1989-06-28 1991-09-13 Elf Aquitaine Dispositif de mesure dynamometrique pour tige de forage
JP2844756B2 (ja) * 1989-12-01 1999-01-06 日本新薬株式会社 脂肪乳剤
WO1992003122A1 (de) * 1990-08-24 1992-03-05 Gregor Cevc Präparat zur wirkstoffapplikation in kleinsttröpfchenform
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
FR2714601B1 (fr) * 1993-12-30 1996-02-09 Oreal Composition dépigmentante pour le traitement simultané des couches superficielles et profondes, son utilisation.
JPH0881360A (ja) * 1994-07-13 1996-03-26 Wakamoto Pharmaceut Co Ltd 安定な脂肪乳剤
ATE223202T1 (de) * 1994-09-30 2002-09-15 Mika Pharma Ges Fuer Die Entwi Pharmazeutische zusammensetzung
IT1270678B (it) * 1994-10-20 1997-05-07 Bayer Ag Liposomi al chetoprofen
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren

Also Published As

Publication number Publication date
HUP9903363A3 (en) 2008-04-28
ES2211984T3 (es) 2004-07-16
KR20000049266A (ko) 2000-07-25
WO1998017255A1 (de) 1998-04-30
KR100446832B1 (ko) 2004-09-04
CN1234736A (zh) 1999-11-10
HUP9903363A2 (hu) 2000-03-28
HK1021622A1 (en) 2000-06-23
DE59610889D1 (de) 2004-02-12
ATE257373T1 (de) 2004-01-15
CN1151777C (zh) 2004-06-02
EP0935457A1 (de) 1999-08-18
CA2268670A1 (en) 1998-04-30
AU724218B2 (en) 2000-09-14
AU4510897A (en) 1998-05-15
BR9612750A (pt) 1999-12-28
EP0935457B1 (de) 2004-01-07
JP2001502676A (ja) 2001-02-27
DE4447287C1 (de) 1996-11-07

Similar Documents

Publication Publication Date Title
MXPA97007996A (es) Preparado para el transporte de sustancias activas a traves de barreras.
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
DK0812198T3 (da) Stabilisering af prostaglandinpræparater
ATE228822T1 (de) Mikroemulsionen zur verwendung als träger zur verabreichung von wirkstoffen
ATE177943T1 (de) Mit polyethylenglycol modifizierte ceramidlipide und liposomen
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
NO992068L (no) Mikroemulsjon og fremgangsmÕte for fremstilling av denne
ES2139574T3 (es) Nuevos gases propulsores y su uso en preparaciones medicas.
ATE169317T1 (de) Pyridobismidazole enthaltendes rigid-rod-polymer
ES2161851T3 (es) Formulacion de agente blanqueador fluorescente.
ES2173115T3 (es) Composiciones de limpieza en microemulsion y emulsion.
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
FR2681784B1 (fr) Composition dermatologique et/ou cosmetologique contenant des retinouides et utilisation de nouveaux retinouides.
GB2302505A (en) Stabilisation of photosensitive materials
ES2091981T3 (es) Procedimiento para la fabricacion de preparaciones de crema estables, hidrofilas o ambifilas, que contienen componentes vesiculares, asi como el uso de las mismas.
ES2059869T3 (es) Preparado farmaceutico que contiene piroxicam para uso topico.
ES2000033A6 (es) Composicion de bitionol sulfoxido porcedimiento para su fabricacion y metodo de utilizacion de aquella
KR890009395A (ko) 흡입제
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
CO4600680A1 (es) Procedimientos para la prevencion de la degradacion de la proteina c
IL139258A0 (en) Stable carbanilide composition
WO1999003509A3 (de) Pharmazeutische mittel enthaltend perfluoralkylgruppenhaltige trijodaromaten und ihre verwendung in der tumortherapie und interventionellen radiologie
KR890001556A (ko) 약제학적 조성물
HU911112D0 (en) Liquid extraction containing active agents of natural origin, and process for the extraction of of the active agents, and cosmetical preparations with possible medicative effect containing such extraction

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: IDEA AG

FG Grant or registration
MM Annulment or lapse due to non-payment of fees